Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2019 – PRNewswire

Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2019 PRNewswire

HOUSTON, May 14, 2019 /PRNewswire/ — Moleculin Biotech, Inc. (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company …